Idiopathic Intracranial Hypertension: Current Neuroophthalmologic Points

Idiopathic intracranial hypertension (ICH) is a neuroophophthalmologic syndrome, the main ophthalmologic symptoms of which are vision loss and bilateral swelling of optic nerve disks (OD). The article provides a review covering various aspects of ICH. Epidemiology: ICH occurs mainly in women aged 20–45 years with body overweight. In this group of patients world incidence is 12–20 per 100 000 of population per year. In the total population it represents 0.5–2 cases per 100 000 of population per year. The eightfold gender predominance of women with ICH is observed. Etiology is not fully known until present time. The reliable connection between obesity in childbearing age women and menstrual cycle disorders as evidences of hormonal changes has been established. The probable mechanisms of increase of ICP are supposed: hyperproduction of and disturbances of its absorption, CSF mechanical pressure on the optic nerve sheath; restriction of venous outflow from the brain due to the pathology of venous sinuses; stimulating effect of abundant vitamin A in diet resulting in the fat tissue formation with the development of obesity; expression of the protein aquaporin, involved in the regulation of body mass and water metabolism in the subarachnoid space. Clinical manifestations. Ophthalmologic symptoms of ICH: transient visual impairment, sustained loss of visual acuity, photopsy, retrobulbar pain, diplopia. Non-ophthalmologic symptoms: headache, throbbing tinnitus, hearing loss, dizziness. Diagnostics. The valuable diagnostic data can be obtained by visual field investigation, ophthalmoscopic examination with revealing of bilateral OD-edema, OD and retinal optical coherent tomography, orbital ultrasound examination, brain MRI with venography. Treatment. Non-drug therapy: weight loss, lowcalorie diet with limited water and salt intake. Drug therapy: long-term oral use of carbonic anhydrase inhibitors (acetazolamide, topiramate). High doses of steroids (methylprednisone) are used for short-term treatment of patients with fulminant disease type before surgery. Surgery: bypass surgery, cerebral venous sinus stenting and fenestrations of the optic nerve sheath: bariatric surgery with reducing of stomach volume.

1. Nikiforov A.S., Guseva M.R. Neuroophthalmology: a guide. Moscow: GEOTAR-Media, 2008 . 624 p. (In Russ.).

2. Astakhov Yu.S., Stepanova E.E., Bikmullin V.N. Benign intracranial hypertension (pseudotumor cerebri). Clinical Ophthalmology = Klinicheskaya oftal’mologiya. 2001;1:8–12 (In Russ.).

3. Friedman D.I. Pseudotumor cerebri. Neurosurgery clinics of North America. 1999;10:609–621. DOI: 10.1016/S1042-3680(18)30161-X

4. Egorova E.S. Risk factors for the optic nerve secondary atrophy development in patients with idiopathic intracranial hypertension. Vestnik of Vitebsk state medical university = Vestnik vitebskogo gosudarstvennogo meditsinskogo universiteta. 2016;15(3):78–83 (In Russ.).

5. Markey K.A., Mollan S.P., Jensen R.H., Sinclair A.J. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. The Lancet Neurology. 2016;15:78–91. DOI: 10.1016/S1474-4422(15)00298-7

6. Parkhomenko E.V., Nartov S.E., Barinov A.N., Karpov D.Yu., Sorokina E.A. The problem of diagnosis and treatment of idiopathic intracranial hypertension. Medical alphabet = Medicinskiy alfavit. 2017;2(15):5–13 (In Russ.).

7. Julayanont P., Karukote A., Ruthirago D., Panikkath D., Panikkath R. Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects. Journal of Pain Research. 2016;9:87–99. DOI: 10.2147/JPR.S60633

8. Magzhanov R.V., Davletova A.I., Bahtiyarova K.Z., Pervushina E.V., Tunik V.F. Benign intracranial hypertension: clinical observations. Annals of Clinical and Experimental Neurology =Annaly Klinicheskoj I Experimental’noy Nevrologii. 2017;11(3):53–59 (In Russ.). DOI: 10.18454/ACEN.2017.3.8

9. Miller N.R., Newman N.J. The essentials: Walsh & Hoyt’s clinical neuro-ophthalmology, 5th edition. Baltimore: Williams & Wilkins. 1999. 820 p.

10. Sugerman H.J., Demaria E.J., Felton W.L., Nakatsuka M., Sismanis A. Increased intra-abdominal pressure and cardiac filling pressures in obesity-associated pseudotumor cerebri. Neurology. 1997;49:507–511. DOI: 10.1212/WNL.49.2.507

11. Sinclair A.J., Burdon M.A., Nightingale P.G., Ball A.K., Good P., Matthews. T.D., Jacks A., Lawden M., Clarke C.E., Stewart P.M., Walker E.A., Tomlinson J.W., Rauz S. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. British.Med.J. 2010;340:c2701. DOI: 10.1136/bmj.c2701

12. Jeyakumar S.M., Vajreswari A. Vitamin A as a key regulator of obesity & its associated disorders: evidences from an obese rat model. Indian J. Med. Res. 2015;141:275– 284. DOI: 10.4103/0971-5916.156554

13. Tabassi A., Salmasi A.H., Jalali M. Serum and CSF vitamin A concentrations in idiopathic intracranial hypertension. Neurology. 2005;64:1893–1896. DOI: 10.1212/01. WNL.0000163556.31080.98

14. Libien J., Kupersmith M.J., Blaner W., McDermott M.P., Gao S., Liu Y., Corbett J., Wall M. Role of vitamin A metabolism in IIH: Results from the idiopathic intracranial hypertension treatment trial. J .Neurol. Sci. 2017;372:78–84. DOI: 10.1016/j. jns.2016.11.014

15. Stiebel-Kalish H., Eyal S., Steiner I. The role of aquaporin-1 in idiopathic and druginduced intracranial hypertension. Med. Hypotheses. 2013;81(6):1059–1062. DOI: 10.1016/j.mehy.2013.10.002

16. Bogomyakova O.B., Stankevich Yu.A., Shraibman L.A., Tulupov A.A. Sexual, age and topographic features of the parameters of cerebrospinal fluid dynamics in patients with benign intracranial hypertension syndrome. Novosibirsk State University Bulletin = Vestnik Novosibirskogo gosudarstvennogo universiteta. 2015;13(4):57–63 (In Russ.).

17. Biousse V., Bruce B.B., Newman N.J. Update on the pathophysiology and management of idiopathic intracranial hypertension. J. Neurol. Neurosurg. Psychiatry. 2012;83(5):488–494. DOI: 10.1136/jnnp-2011-302029

18. Hayreh S.S. Pathogenesis of optic disc edema in raised intracranial pressure. Prog. Retin. Eye Res. 2016;50:108–144. DOI: 10.1016/j.preteyeres.2015.10.001

19. Hoffmann J., Kreutz K.M., Csapó-Schmidt C., Becker N., Kunte H., Fekonja L.S., Jadan A., Wiener E. The effect of CSF drain on the optic nerve in idiopathic intracranial hypertension. J.Headache Pain. 2019;20:59. DOI: 10.1186/s10194-019-1004-1

20. Likhachev S.A., Astapenko A.V., Pleshko I.V., Korbut T.V., Antonenko A.I., Naumenko D.V., Gvishch T.G., Merkul O.V. Idiopathic intracranial hypertension (IIH). Neurology and neurosurgery. Eastern Europe = Nevrologiya i nejrohirurgiya. Vostochnaya Evropa. 2015;2(26):145 (In Russ.).

21. Jindal M., Hiam L., Raman A., Rejali D. Idiopathic intracranial hypertension in otolaryngology. Eur. Arch. Otorhinolaryngol. 2009;266(6):803–806. DOI: 10.1007/ s00405-009-0973-0

22. Chen J.J., Thurtell M.J., Longmuir R.A., Garvin M.K., Wang J.K., Wall M., Kardon R.H. Causes and prognosis of visual acuity loss at the time of initial presentation in idiopathic intracranial hypertension. Invest. Ophthalmol. Vis. Sci. 2015;56:3850–3859. DOI: 10.1167/iovs.15-16450

23. Golenkov A.K. The value of spontaneous pulse of retinal veins in the diagnosis of intracranial hypertension. Ophthalmological Journal = Oftal’mologicheskiy zhurnal. 1982;5(253):265–267 (In Russ.).

24. Frisen L. Swelling of the optic nerve head: a staging scheme. J. Neurol. Neurosurg. Psychiatry. 1982;45(1):13–18. DOI: 10.1136/jnnp.45.1.13

25. Sibony P.A., Kupersmith M.J., Feldon S.E., Wang J.K., Garvin M, OCT Substudy Group for the NORDIC Idiopathic Intracranial Hypertension Treatment Trial. Retinal and Choroidal Folds in Papilledema. Invest. Ophthalmol. Vis. Sci. 2015;56(10):5670–5680. DOI: 10.1167/iovs.15-17459

26. Visa Reñé N., Paredes Carmona F. Pseudo-Foster Kennedy syndrome due to idiopathic intracranial hypertension. Arch. Soc. Esp. Oftalmol. 2019;94(12):598–601. DOI: 10.1016/j.oftal.2019.09.006

27. Eliseeva N.M., Serova N.K., Shifrin M.A. The role of laser retinotomography in the study of patients with congestive optic nerve discs. Annales of Ophthalmology =Vestnik oftal’mologii. 2005;5:29–31 (In Russ.).

28. Aojula A., Mollan S.P., Horsburgh J., Yiangou A., Markey K.A., Mitchell J.L., Scotton W.J., Keane P.A., Sinclair A.J. Segmentation error in spectral domain optical coherence tomography measures of the retinal nerve fiber layer thickness in idiopathic intracranial hypertension. BMC Ophthalmol. 2018;17(1):257. DOI: 10.1186/ s12886-017-0652-7

29. Albrecht P., Blasberg C., Ringelstein M., Müller A.K., Finis D., Guthoff R., Kadas E.M., Lagreze W., Aktas O., Hartung H.P., Paul F., Brandt A.U., Methner A. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension. J.Neurol. 2017;264(7):1370–1380. DOI: 10.1007/s00415017-8532-x

30. Goldhagen B.E., Bhatti M.T., Srinivasan P.P., Chiu S.J., Farsiu S., El-Dairi M.A. Retinal Atrophy in Eyes With Resolved Papilledema Detected by Optical Coherence Tomography. J. Neuroophthalmol. 2015;35(2):122–126. DOI: 10.1097/ WNO.0000000000000210

31. Gampa A., Vangipuram G., Shirazi A., Moss H.E. Quantitative association between peripapillary Bruch’s membrane shape and intracranial pressure. Invest. Ophthalmol. Vis. Sci. 2017;58:2739–2745. DOI: 10.1167/iovs.17-21592

32. Costello F., Malmqvist L., Hamann S. The role of optical coherence tomography in differentiating optic disc drusen from optic disc edema. Asia-Pac. J. Ophthalmology (Phila) 2018;7(4):271–279. DOI: 10.22608/APO.2018124

33. Auinger P., Durbin M., Feldon S., Garvin M., Kardon R., Keltner J., Kupersmith M., Sibony P., Plumb K., Wang J., Werner J.S. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial. Ophthalmology. 2015;122(9):1939–1945.e2. DOI: 10.1016/j.ophtha.2015.06.003

34. Miljic D., Pekic S., Popovic V. Empty Sella. [www.endotext.org] [обновлено 1 октября 2018; процитировано 17 мая 2020]. URL: https://www.ncbi.nlm.nih. gov/books/NBK532084

35. Bergland R.M., Ray B.S., Torack R.M. Anatomical variation in the pituitary gland and adjacent structures in 225 human autopsy cases. J.Neurosurg. 1968;28(2):93–99. DOI: 10.3171/jns.1968.28.2.0093

36. Bjerre P. The empty sella. A reappraisal of etiology and pathogenesis. Acta Neurol. Scand. 1990;130:1–25.

37. Xu W., Gerety P., Aleman T., Swanson J., Taylor J. Noninvasive methods of detecting increased intracranial pressure. Childs Nerv Syst. 2016; 32(8):1371-1386. DOI: 10.1007/s00381-016-3143-x

38. Wall M. Idiopathic Intracranial Hypertension. Neurol. Clin. 2010;28(3):593–617. DOI: 10.1016/j.ncl.2010.03.003

39. Mizetskaya E.A., Snigireva R.Ya. Endocrine disorders in the “empty” sella turcica. Burdenko’s Journal of Neurosurgery = Zhurnal “Voprosy neirokhirurgii” imeni N.N. Burdenko. 1984;6:12–17 (In Russ.).

40. Bettie А.М., Trope G.E. Glaucomatous optic neuropathy and field loss in primary empty sella syndrome. Can. J. Ophtalmology. 1991;26(7):377–382.

41. Jaja-Albarran A., Bayort J., De Juan M., Benito C. Spontaneous partial empty sella: A study of 41 cases. Exp. Clin. Endocrinol. 1984;83(1):63–72. DOI: 10.1055/s-00291210313

42. Subramaniam S., Fletcher W.A. J Obesity and Weight Loss in Idiopathic Intracranial Hypertension: A Narrative Review. Neuroophthalmol. 2017;37(2):197–205. DOI: 10.1097/WNO.0000000000000448

43. Pizova N.V. Idiopathic intracranial hypertension and the place of acetazolamide in treatment. Consilium Medicum. Neurology and rheumatology. (App.) =Consilium Medicum. Nevrologiya i revmatologiya. (Pril.). 2016;1:60– 64 (In Russ.).

44. Wall M., Johnson C.A., Cello K.E., Zamba K.D., McDermott M.P., Keltner J.L. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT). Invest. Ophthalmol. Vis. Sci. 2016;57(3):805–812. DOI: 10.1167/iovs.1518626

45. Celebisoy N., Gokcay F, Sirin H., Akyurekli O. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol. Scand. 2007;116(5):322–327. DOI: 10.1111/j.1600-0404.2007.00905.x

46. Yun S.H., Lavin P.J., Schatz M.P., Lesser R.L. Topiramate-induced palinopsia: a case series and review of the literature. J Neuroophthalmol. 2015;35(2):148–151. DOI: 10.1097/WNO.0000000000000216

47. Thurtell M.J., Wall M. Idiopathic intracranial hypertension (pseudotumor cerebri): recognition, treatment, and ongoing management. Curr. Treat.Options Neurol. 2013;15(1):1–12. DOI: 10.1007/s11940-012-0207-4

48. Chatziralli I., Theodossiadis P., Theodossiadis G., Asproudis I. Perspectives on diagnosis and management of adult idiopathic intracranial hypertension. Graefes Arch. Clin. Exp.Ophthalmol. 2018;256(7):1217–1224. DOI: 10.1007/s00417-018-3970-4

49. Kalyvas A.V., Hughes M., Koutsarnakis C., Moris D., Liakos F., Sakas D.E., Stranjalis G., Fouyas I. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir. (Wien). 2017;159(1):33–49. DOI: 10.1007/s00701-016-3010-2

50. Daggubati L.C., Liu K.C. Intracranial venous sinus stenting: a review of idiopathic intracranial hypertension and expanding indications. Cureus. 2019 F;11(2):e4008. DOI: 10.7759/cureus.4008

51. Leishangthem L., SirDeshpande P., Dua D., Satti S.R. Dural venous sinus stenting for idiopathic intracranial hypertension: An updated review. J. Neuroradiol. 2019;46(2):148–154. DOI: 10.1016/j.neurad.2018.09.001

52. Kanagalingam S., Subramanian P.S. Cerebral venous sinus stenting for pseudotumor cerebri: A review. Saudi Journal of Ophthalmology. 2015;29(1):3–8. DOI: 10.1016/j.sjopt.2014.09.007

53. Chaudhry S., Bryant T.K., Peeler C.E. Venous sinus stenting in idiopathic intracranial hypertension: a safer surgical approach? Curr Opin Ophthalmol. 2016;27(6):481– 485. DOI: 10.1097/ICU.0000000000000315

54. Spitze A., Lam P., Al-Zubidi N., Yalamanchili S., Lee A.G. Controversies: Optic nerve sheath fenestration versus shunt placement for the treatment of idiopathic intracranial hypertension. Indian J. Ophthalmol. 2014;62(10):1015–1021. DOI: 10.4103/0301-4738.146012

55. Adesina O., Mahabadi N., Patel B.C. Optic Nerve Decompression. [www.statpearls. com] [обновлено 19 октября 2019; процитировано 17 мая 2020] URL: https:// www.ncbi.nlm.nih.gov/books/NBK538300/

56. Lagrèze W.A., Gross N., Biermann J. Indikation und Technik der transkonjunktivalen Optikusscheidenfensterung. [Indications and technique for transconjunctival optic nerve sheath fenestration: Video article] Ophthalmologe. 2018;114:953–958. DOI: 10.1007/s00347-017-0563-2

57. Yildirim A.E., Karaoglu D., Divanlioglu D., Secen A.E., Gurcay A.G., Cagil E., Belen A.D. Endoscopic endonasal optic nerve decompression in a patient with pseudotumor cerebri. J. Craniofac. Surg. 2015;26(1):240–242. DOI: 10.1097/ SCS.0000000000001294

58. Tarrats L., Hernández G., Busquets J.M., Portela J.C., Serrano L.A., GonzálezSepúlveda L., Sánchez-Pérez J.R. Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension. Int. Forum Allergy Rhinol. 2017;7(6):615–623. DOI: 10.1002/alr.21927

59. Manfield J.H., Yu K.K., Efthimiou E., Darzi A., Athanasiou T., Ashrafian H. Bariatric Surgery or Non-surgical Weight Loss for Idiopathic Intracranial Hypertension? A Systematic Review and Comparison of Meta-analyses. Obes Surg. 2017;27(2):513– 521. DOI: 10.1007/s11695-016-2467-7

60. Cazzo E., Gestic M.A., Utrini M.P., Mendonça Chaim F.D., Mendonça Chaim F.H., Cândido E.C., da Silveira Jarolavsky L.B., de Almeida A.M.N., Pareja J.C., Chaim E.A. Bariatric surgery as a treatment for pseudotumor cerebri: case study and narrative review of the literature. Sao Paulo Med. J. 2017;136(2):182–187. DOI: 10.1590/1516-3180.2016.0305060117